We identified four significant KEGG pathways that were implicated in digestive tumor immunotherapy and TIM-3; pathways of pancreatic cancer, NF-Kappa B signaling pathway, Toll-like receptor signaling pathway and C-type lectin receptor signaling pathway. The gene discussed is HAVCR2; the disease is familial pancreatic carcinoma.